Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

Stopped \[The risk of inhaled allergen challenge and anakinra treatment outweigh benefits to participants with allergic asthma due to the COVID-19 pandemic.

Conditions

• Asthma

Interventions

• BIOLOGICAL: Anakinra
• OTHER: Anakinra Matching Placebo
• DRUG: Dermatophagoides Farinae

Sponsor

University of North Carolina, Chapel Hill

Collaborators

• [object Object]